Keyboard design for phase I drug-combination trials
Keyboard design for phase I drug-combination trials
复制标题
DOI:
10.1016/j.cct.2020.105972
复制
发表时间:
2020-05-01
影响因子:
2.2
通讯作者:
Yuan, Ying
中科院分区:
文献类型:
--
作者:
Pan, Haitao;Lin, Ruitao;Yuan, Ying
The Keyboard design is a novel model-assisted dose-finding method to find the maximum tolerated dose (MTD) for single-agent trials. The Keyboard design is easy to implement and has superior performance in comparison to more complicated model-assisted designs. In this article, we extend the Keyboard design to dual-agent dose-finding trials. The proposed Keyboard combination trial design maintains the simplicity of the original single-agent Keyboard design, and its dose escalation and deescalation rules can be pre-tabulated before conducing the trial. We show that the Keyboard combination design has desirable theoretical properties, including the optimality of its decision rules, coherence in dose transition, and convergence to the target dose. Extensive simulations are conducted to evaluate the performance of the proposed Keyboard combination design using a novel, random two-dimensional dose-toxicity scenario generating algorithm. The simulation results confirm the desirable and competitive operating characteristics of the Keyboard design. An R Shiny application is available at www.trialdesign.org to implement the Keyboard combination design.